Flow cytometric detection of total and serine 473 phosphorylated Akt
- 1 January 2002
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 86 (4) , 704-715
- https://doi.org/10.1002/jcb.10262
Abstract
The evaluation of regulatory proteins is important for biological studies and is also established as a prognostic marker for cancer diagnosis. Very recently, it has been highlighted that the serine/threonine kinase Akt plays a fundamental role in survival pathways and is also involved in the onset of resistance to anti‐neoplastic drugs and ionizing radiation in cell lines derived from solid tumors. For its full activation Akt needs to be phosphorylated on Serine 473 residue. Molecules that are fundamental in determining resistance to therapeutic treatments might serve in the future as clinical markers to tailor therapy and/or predict treatment response. The aim of this study was to ascertain whether or not flow cytometric analysis of total Akt and of its form phosphorylated on Serine 473 could be related to standard techniques such as Western blotting with phosphospecific antibodies and in vitro kinase assay. To this end, we employed as experimental models HL‐60 and PC‐12 lines in which there is an enhancement of Akt activity. Our results showed that flow cytometry analysis, performed on fixed and permeabilized cells, correlated well with the results provided by in vitro activity assays and Western blots. Therefore, our findings might indicate that flow cytometric study of Akt (both total and phosphorylated) content may be applied in routine work for phenotyping of hematological and non‐hematological neoplasias, and allow for its use as a useful marker for the classification and the prognosis of neoplastic diseases. J. Cell. Biochem. 86: 704–715, 2002.Keywords
This publication has 27 references indexed in Scilit:
- Dopamine depletion and subsequent treatment with l‐DOPA, but not the long‐lived dopamine agonist pergolide, enhances activity of the Akt pathway in the rat striatumJournal of Neurochemistry, 2007
- The protein kinase B/Akt signalling pathway in human malignancyCellular Signalling, 2002
- Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistryBlood, 2002
- Ten years of protein kinase B signalling: a hard Akt to followPublished by Elsevier ,2001
- AKT plays a central role in tumorigenesisProceedings of the National Academy of Sciences, 2001
- Synthesis and Function of 3-Phosphorylated Inositol LipidsAnnual Review of Biochemistry, 2001
- The PI3K–PDK1 connection: more than just a road to PKBBiochemical Journal, 2000
- AKT/PKB and Other D3 Phosphoinositide-Regulated Kinases: Kinase Activation by Phosphoinositide-Dependent PhosphorylationAnnual Review of Biochemistry, 1999
- Nerve growth factor promotes activation of the α, β and γ isoforms of protein kinase B in PC12 pheochromocytoma cellsEuropean Journal of Biochemistry, 1998
- Bcl-2 Expression in Acute Myeloblastic Leukaemia: Relationship with Autonomous Growth and CD34 Antigen ExpressionLeukemia & Lymphoma, 1997